GPHRB

GPHRB (GPR89B) is an orphan multi-pass transmembrane protein that operates within the endomembrane system, where it links nucleotide-sugar transport machinery to organelle development and cell-size regulation (PMID:34242836, PMID:25380752). In mammalian cells it physically associates with the nucleotide sugar transporters SLC35A2, SLC35A3, and SLC35A4, an interaction confirmed by co-immunoprecipitation and split-luciferase complementation, positioning GPHRB in the regulation of glycosylation through ion homeostasis (PMID:34242836). Its stability and function are governed by the small GTPase RABL3: RABL3 binds and stabilizes GPHRB, and a loss-of-function Gpr89 allele phenocopies Rabl3 disruption in lymphoid development, establishing GPHRB as a downstream effector in lymphopoiesis (PMID:32220963). In the Dictyostelium ortholog, the protein localizes to the endoplasmic reticulum and Golgi, and its loss causes developmental defects without measurable impairment of membrane-protein processing or glycosylation (PMID:25380752). Humanization of zebrafish ortholog knockouts with human GPR89B mRNA produces dosage-dependent brain expansion, assigning GPHRB a direct role in brain-size regulation (PMID:40695280). Beyond these findings, the molecular transport activity of GPHRB has not been directly demonstrated in the available corpus.

1. 2014 Medium

   Established the subcellular compartment in which GPHRB acts and tested whether it is required for canonical secretory-pathway functions, by characterizing the Dictyostelium ortholog.

   Evidence Gene knockout, immunofluorescence localization, and glycosylation assays in Dictyostelium discoideum

   PMID:25380752

   Open questions at the time

   • No molecular transport substrate identified
   • Developmental phenotype mechanism not linked to a biochemical activity
   • Glycosylation unaffected, leaving the functional output undefined
2. 2020 Medium

   Placed GPHRB in a defined regulatory hierarchy by showing it is stabilized by and acts downstream of the GTPase RABL3 in lymphoid development.

   Evidence ENU mutagenesis genetic epistasis (phenocopy) combined with co-immunoprecipitation/association assay in mouse

   PMID:32220963

   Open questions at the time

   • Biochemical consequence of RABL3 binding on GPHRB activity unknown
   • Mechanism connecting GPHRB to lymphopoiesis not resolved
   • Single lab
3. 2021 Medium

   Identified direct physical partners, connecting GPHRB to nucleotide-sugar transport and a candidate role in glycosylation/ion homeostasis.

   Evidence Co-IP/mass spectrometry with NanoBiT split-luciferase confirmation of SLC35A2/A3/A4 interactions

   PMID:34242836

   Open questions at the time

   • Functional consequence of SLC35 binding not demonstrated
   • Ion homeostasis role inferred, not measured
   • Single lab
4. 2025 Medium

   Provided direct functional evidence that human GPHRB dosage regulates brain size, via cross-species humanization.

   Evidence Zebrafish CRISPR ortholog knockout rescued with human GPR89B mRNA, scored by brain size

   PMID:40695280

   Open questions at the time

   • Molecular pathway linking GPHRB to brain expansion unknown
   • Cell-type responsible not defined
   • Single study
5. 2025 Low

   Reassigned GPHRB structurally from a GPCR to a solute-carrier-like transporter, reframing its likely molecular activity.

   Evidence AlphaFold-based structural modeling, phylogenetics, and genomic synteny analysis

   PMID:41282416

   Open questions at the time

   • Computational prediction only, transport activity not experimentally validated
   • No identified transported solute
   • No experimental structure

• The biochemical activity of GPHRB and the substrate it transports or regulates remain undefined, leaving its molecular function unresolved.
• No direct demonstration of transport activity
• No mechanistic link between SLC35 binding, RABL3 regulation, and the brain-size/developmental phenotypes